More News

21 Jul 2017 Aptevo Therapeutics and Alligator Bioscience announce plans to co-develop novel bispecific antibody for tumor-directed immunotherapy
20 Jul 2017 AMO Pharma Enters into Development and License Agreement with Numedicus Limited for Rett Syndrome Program
20 Jul 2017 Ablynx and Sanofi enter into a strategic collaboration to develop nanobody product candidates focused on immune-mediated inflammatory diseases
19 Jul 2017 ViraCyte Enters Exclusive License Agreement with Baylor College of Medicine for T Cell Immunotherapies Targeting Viruses
19 Jul 2017 Invenra Enters Collaboration Agreement with Merck to Identify Therapeutic Antibodies Against Challenging Target
19 Jul 2017 ELSALYS BIOTECH and the prestigious German cancer research institute DKFZ initiate the development of ELB021 in B-Cell leukemia with the support of EU
19 Jul 2017 Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation
18 Jul 2017 Shire Expands Broad Monoclonal Antibody Research Platform, Enters License Agreement for Novimmune Bi-specific Antibody
18 Jul 2017 PeptiDream and Kleo Pharmaceuticals Announce Collaboration Agreement to Develop Novel Immunotherapies for Oncology
18 Jul 2017 Abzena and Telix Sign Licence Agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies
17 Jul 2017 Ligand Enters Into Commercial License and Supply Agreement with Amgen for Rights to Use Captisol in the Formulation of AMG 330
12 Jul 2017 ERYTECH Announces Collaboration with Queen’s University to Advance its Product Candidate for Rare Metabolic Disorders
12 Jul 2017 Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
12 Jul 2017 CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration
11 Jul 2017 Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Announce Cancer Research Collaboration
11 Jul 2017 Abzena and OBI Pharma Sign ThioBridge™ Licence Agreement
11 Jul 2017 Sanofi to acquire Protein Sciences
08 Jul 2017 Oncology Venture and Eisai Forge Exclusive Global License Agreement for Clinical Stage Oncology Drug PARP Inhibitor E7449 / 2X-121
07 Jul 2017 Entasis Therapeutics and the Global Antibiotic Research & Development Partnership (GARDP) to Develop a New Treatment for Drug-Resistant Gonorrhea
06 Jul 2017 Evotec Received Funding from IFB Hamburg to Identify Antibody-Mediated T-cell Immunotherapies
06 Jul 2017 Celgene Corporation Enters Into Global Strategic Immuno-Oncology Collaboration with BeiGene to Advance PD-1 Inhibitor Program for Solid Tumor Cancers
06 Jul 2017 Trillium Provides Update on Small Molecule Programs
05 Jul 2017 Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform
04 Jul 2017 Sun Pharma & Samsung BioLogics announce strategic manufacturing tie-up for Tildrakizumab
30 Jun 2017 Servier and Transgene Have Become Partners to Apply Viral Vectorization Technology to the Engineering of Allogenic CAR-T

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing